EBOS Group Limited (NZSE:EBO) shareholders are probably feeling a little disappointed, since its shares fell 3.9% to NZ$35.91 in the week after its latest half-yearly results. EBOS Group reported in line with analyst predictions, delivering revenues of AU$6.5b and statutory earnings per share of …
Insmed Incorporated (NASDAQ:INSM) Q4 2023 Earnings Call Transcript February 22, 2024 Insmed Incorporated misses on earnings expectations. Reported EPS is $-1.28 EPS, expectations were $-1.13. Insmed Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third …
In this article, we will take a detailed look at the12 Best Gold Stocks Under $25. For a quick overview of such stocks, read our article 5 Best Gold Stocks Under $25. Gold prices slipped recently amid indications from several Fed officials that the …
WPP plc (NYSE:WPP) Q4 2023 Earnings Call Transcript February 22, 2024 WPP plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Mark Read: Thank you very much and welcome everybody …
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Masimo (MASI) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? …
Builds on the recent capital raise to provide SunPower with access to more than half a billion dollars in financing RICHMOND, Calif., Feb. 23, 2024 /PRNewswire/ -- SunPower Corp. (NASDAQ:SPWR), (the "Company" or "SunPower"), a leading residential solar technology and energy services provider, today …
Triple Flag Precious Metals (TSE:TFPM) Full Year 2023 Results Key Financial Results Revenue: US$204.0m (up 34% from FY 2022). Net income: US$36.3m (down 34% from FY 2022). Profit margin: 18% (down from 36% in FY 2022). EPS: US$0.18 (down from US$0.35 in FY 2022). …
Travere Therapeutics, Inc. Committee for Medicinal Products for Human Use (CHMP) recommends approval of the conditional marketing authorization (CMA) for sparsentan for the treatment of IgA nephropathy (IgAN) in Europe Positive CHMP opinion is based on pivotal Phase 3 PROTECT Study results European Commission …
Plug Power, Inc. 8-year partnership and $20,000,000 expansion underscores Uline’s commitment to Plug’s hydrogen and fuel cell solutions, significantly enhancing efficiency of operations LATHAM, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for …
Key Insights Superior Plus' estimated fair value is CA$16.56 based on Dividend Discount Model Superior Plus is estimated to be 42% undervalued based on current share price of CA$9.60 Analyst price target for SPB is CA$13.16 which is 21% below our fair value estimate …